To expand access to advanced oral dispersing tablet solutions across Latin America
InstaPill, a globally recognised CDMO specialising in orally disintegrating tablets, announced its strategic partnership with Aché Laboratórios Farmacêuticos (Aché) to co-develop the first of several prescription pharmaceutical products using InstaPill’s proprietary lyophilized oral dispersing tablet (ODT) platform for the Brazilian and other Latin American markets.
Ankit Gupta, CEO, InstaPill, stated, “We are pleased with our maiden partnership with Aché, which pairs InstaPill’s core technical capabilities in oral lyophilizates with Aché’s leading go-to-market expertise. This represents a significant step forward in our mission to expand InstaPill’s unique technology throughout Latin America.”
